Hepatitis C Treatment: News & Analysis
- FDA Drug Safety Communication: Important Drug Interactions Between Victrelis (Boceprevir) and Ritonavir-Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor Drugs (February 8, 2012)
From U.S. Food and Drug Administration
- Results of Pharmacokinetic Study in Healthy Volunteers Given Victrelis (Boceprevir) and Ritonavir-Boosted HIV Protease Inhibitors May Indicate Clinically Significant Drug Interactions for Patients Coinfected With Chronic Hepatitis C and HIV (February 6, 2012)
To read PDF, click here.
From Merck & Co., Inc.
 Incivek (Telaprevir) in HIV/HCV-Coinfected Patients: A Look at Recent Research -- A Blog Entry by Barbara McGovern, M.D. (February 6, 2012)
From TheBody.com
- New Hepatitis C Treatment Available in Australia (February 2, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Looking Forward to a Bright New Year in HIV/HCV Treatment: A Blog Entry by Barbara McGovern, M.D. (January 10, 2012)
From TheBody.com
 Top 10 HIV/AIDS-Related Clinical Developments of 2011 (December 1, 2011)
David Alain Wohl, M.D., on HIV treatment as prevention; the dawning of pre-exposure prophylaxis (PrEP), but with women absent; the concept of "viremia copy-years"; the impact of race and gender on HIV treatment outcomes; setbacks for two treatment approaches involving Isentress; new hepatitis C therapies; a new once-daily HIV pill; the rising rates of HIV among black MSM; and what comes after "test and treat."
From TheBody.com
- Vertex, J&J Hepatitis C Drug Gets European Union Nod (September 22, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection (September 20, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- The Hepatitis C Treatment Pipeline (September 2011)
In 2011 Pipeline Report, from Treatment Action Group and HIV i-Base
- FDA Approve Telaprevir (Incivek) to Treat Hepatitis C (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- FDA Approve Boceprevir (Victrelis) for HCV (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- European Union Approves Merck's Hepatitis C Drug Victrelis (July 20, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
 Q&A on Hepatitis C and African Americans With Jonathan McCone, M.D., Victrelis Researcher (July 6, 2011)
From TheBody.com
- New Vertex Ads Focus on Disease, Not the Actual Treatment (June 28, 2011)
In The Boston Globe
- Why Incivek and Victrelis Herald a New Era in Hepatitis C Treatment (June 2, 2011)
From TheBody.com
- NICE to Appraise Hep C Drugs Victrelis and Telaprevir (May 26, 2011)
In InPharm
- FDA Approves Incivek (Telaprevir) for Hepatitis C (May 23, 2011)
From U.S. Food and Drug Administration
- Finally, Progress Against a Silent Killer; Brand New Treatment for Hepatitis C Increases Importance of Getting Tested (May 20, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Australia: Clinical Experience With the Treatment of Hepatitis C Infection in Patients on Opioid Pharmacotherapy (May 20, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- A New Wave of Hepatitis C (May 20, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Merck's Hepatitis C Drug Wins FDA Approval (May 18, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
|
Advertisement
|
Email
Glossary
